Building the infrastructure layerfor tech-enabled drug discovery
We are the only biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation.
We integrate AI with three proprietary data streams – computational data, wet lab proxy biological data, and wet lab ground truth biological data – to deliver novel drug candidates and software solutions to leading pharma and tech partners, and advance our internal pipeline for neurological, autoimmune diseases, and cancer.
Want more insights? Check out our posts.
Have a lookMicrosoft partners with Boston biotech to build 'drug discovery on steroids'
3m read 29th April, 2024.
The rise of subscription-based AI platforms for drug discovery
2m read 10th April, 2024.
Making Undruggable Targets a Thing of the Past
0m read 4th April, 2024.